U.S., Feb. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07425912) titled 'Real-World Evaluation of TouchCare Nano in Pediatric Type 1 Diabetes' on Feb. 07.
Brief Summary: The goal of this observational study is to learn how well the TouchCare Nano automated insulin delivery system works and how safe it is for children and adolescents with type 1 diabetes in everyday medical care.
The main questions this study aims to answer are:
Does using the TouchCare Nano system help people with type 1 diabetes spend more time with their blood glucose in a healthy range? Are serious low blood sugar events or diabetic ketoacidosis uncommon while using this system in daily life? Participants are children and adolescent...